The India Cancer Immunotherapy Market is on the verge of a major transformation, with projections indicating a substantial increase in market value from USD 3.34 billion in 2018 to an anticipated USD 6.0 billion by 2035. This represents a compound annual growth rate (CAGR) of 4.995% from 2025 onward, highlighting the growing adoption of advanced treatment modalities in the country. As cancer...